Serum [Gamma]-Glutamyltransferase was Differently Associated with Microalbuminuria by Status of Hypertension Or Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (Lipids, Lipoproteins, And Cardiovascular Risk Factors) Serum [Gamma]-Glutamyltransferase was Differently Associated with Microalbuminuria by Status of Hypertension Or Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (Lipids, Lipoproteins, And Cardiovascular Risk Factors)

Serum [Gamma]-Glutamyltransferase was Differently Associated with Microalbuminuria by Status of Hypertension Or Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (Lipids, Lipoproteins, And Cardiovascular Risk Factors‪)‬

Clinical Chemistry 2005, July, 51, 7

    • CHF 3.00
    • CHF 3.00

Publisher Description

Serum [gamma]-glutamyltransferase (GGT) [5] concentrations within the physiologic range have been strongly associated with most cardiovascular disease risk factors and predicted the development of heart disease, hypertension, stroke, and type 2 diabetes (1-6). In particular, serum GGT concentrations have shown a strong graded relationship with incident diabetes, suggesting a role in the pathogenesis of diabetes (2, 3). Although serum GGT activity has commonly been used as a marker for excessive alcohol consumption or liver diseases (7), neither alcohol consumption nor liver dysfunction likely explain the association between serum GGT and diabetes (2, 3). A series of Coronary Artery Risk Development [gamma] Adults (CARDIA) studies (3, 8, 9) suggested that oxidative stress might explain these associations because serum GGT within the physiologic range had dose-response relationships with serum and/or dietary antioxidant vitamins and markers of oxidative stress such as [F.sub.2]-isoprostanes. Although the relationship between cellular GGT and serum GGT is not known, cellular GGT has been known to play an important role in antioxidant defense systems (10-12); paradoxically, cellular GGT may also be involved in the generation of reactive oxygen species in the presence of transition metals (13-16). Recently, a role of serum GGT as an early and sensitive marker of oxidative stress was reviewed (17). Microalbuminuria, slightly increased albumin excretion in the urine, is now considered to be a predictor of atherosclerotic diseases (18,19). Recent evidence strongly suggested that microalbuminuria is an independent predictor of cardiovascular disease in diabetic or hypertensive patients, in elderly patients, and in the general population (18,19). The mechanisms linking microalbuminuria and risk for cardiovascular disease are not fully understood; a recent concept is that microalbuminuria is a marker of endothelial dysfunction (18,19). Generalized endothelial dysfunction has been hypothesized to be the underlying factor for microalbuminuria on the one hand and the underlying factor for increased cardiovascular risk on the other. Accumulating evidence suggests that oxidative stress alters many functions of the endothelium, including modulation of vasomotor tone (20).

GENRE
Science & Nature
RELEASED
2005
1 July
LANGUAGE
EN
English
LENGTH
21
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
256.4
KB

More Books by Clinical Chemistry

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report) The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report)
2009
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs) Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs) Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005
Newborn Screening for Lysosomal Storage Disorders (Editorials) Newborn Screening for Lysosomal Storage Disorders (Editorials)
2005